SEATTLE, Nov. 26, 2008 -- Brain cancer remains one of the deadliest
diseases, but Swedish
Neuroscience Institute (SNI) neurosurgeon and researcher Greg
Foltz, M.D., who is based at Swedish/Cherry
Hill, is tapping
into the science and biotech that Seattle is famed for in his quest for
better treatments and a cure. Already, the work is leading to personalized treatment
plans based on genetic analysis of every tumor.
To read this article on The Seattle Times' Web site, click here.
And to learn more about SNI's Center for Advanced Brain Tumor Treatment, click here and here.
###